Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
SCHWARTZ ALICE N
   2. Issuer Name and Ticker or Trading Symbol
BIO RAD LABORATORIES INC [BIO, BIOB] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE		 3. Date of Earliest Transaction (Month/Day/Year)
12/03/2012
(Street)

HERCULES, CA 94547		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Bio-Rad A Common Stock               2,772,912 D  
Bio-Rad A Common Stock               34,311 I By Trust
Bio-Rad B Common Stock 12/03/2012   M   8,000 (1) A $ 36 489,436 (2) D  
Bio-Rad B Common Stock 12/03/2012   M   7,608 (1) A $ 53.5 497,044 D  
Bio-Rad B Common Stock 12/03/2012   M   8,227 (1) A $ 56.4 505,271 D  
Bio-Rad B Common Stock 12/03/2012   M   8,413 (1) A $ 63 513,684 D  
Bio-Rad B Common Stock 12/03/2012   M   4,000 (1) A $ 75 517,684 D  
Bio-Rad B Common Stock 12/03/2012   M   3,000 (1) A $ 88.48 520,684 D  
Bio-Rad B Common Stock 12/03/2012   M   2,000 (1) A $ 75.38 522,684 D  
Bio-Rad B Common Stock 12/03/2012   M   1,000 (1) A $ 84.57 523,684 D  
Bio-Rad B Common Stock 12/03/2012   F   24,014 D $ 104.85 499,670 D  
Bio-Rad B Common Stock 12/03/2012   G   720 D $ 0 498,950 D  
Bio-Rad B Common Stock               4,060,054 I By Blue Raven Partners, L.P. (3)
Bio-Rad B Common Stock               41,176 I By DANSA Partners Limited (4)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $ 36 12/03/2012   M     8,000   (5) 02/05/2013 Bio-Rad B Common Stock 8,000 $ 0 0 D  
Non-Qualified Stock Option (right to buy) $ 53.5 12/03/2012   M     7,608   (6) 02/04/2014 Bio-Rad B Common Stock 7,608 $ 0 0 D  
Non-Qualified Stock Option (right to buy) $ 56.4 12/03/2012   M     8,227   (7) 02/09/2015 Bio-Rad B Common Stock 8,227 $ 0 0 D  
Non-Qualified Stock Option (right to buy) $ 63 12/03/2012   M     8,413   (8) 04/03/2016 Bio-Rad B Common Stock 8,413 $ 0 0 D  
Non-Qualified Stock Option (right to buy) $ 75 12/03/2012   M     4,000   (9) 08/01/2017 Bio-Rad B Common Stock 4,000 $ 0 0 D  
Non-Qualified Stock Option (right to buy) $ 88.48 12/03/2012   M     3,000   (10) 06/11/2018 Bio-Rad B Common Stock 3,000 $ 0 0 D  
Non-Qualified Stock Option (right to buy) $ 75.38 12/03/2012   M     2,000   (11) 06/10/2019 Bio-Rad B Common Stock 2,000 $ 0 0 D  
Non-Qualified Stock Option (right to buy) $ 84.57 12/03/2012   M     1,000   (12) 09/08/2020 Bio-Rad B Common Stock 1,000 $ 0 0 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
SCHWARTZ ALICE N
C/O BIO-RAD LABORATORIES, INC.
1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547		   X   X    

Signatures

 Alice N. Schwartz   12/05/2012
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The stock option exercise reported is the exercise of derivative securites acquired upon the death of the reporting person's spouse, David Schwartz, former Chairman of the Board of Bio-Rad Laboratories, Inc. and beneficial owner of more than 10% of the Company's Common Stock.
(2) 1,002 unvested restricted stock Class B shares held by the reporting person's late spouse, David Schwartz, were forfeited as of the date of his death, April 1, 2012.
(3) The shares are held by a limited partnership of which the reporting person is a limited and general partner.
(4) The shares are held by a limited partnership of which the reporting person is a general partner.
(5) The stock option became exercisable in five equal annual installments beginning on February 5, 2004.
(6) The stock option became exercisable in five equal annual installments beginning on February 4, 2005.
(7) The stock option became exercisable in five equal annual installments beginning on February 9, 2006.
(8) The stock option became exercisable in five equal annual installments beginning on April 3, 2007
(9) The stock option became exercisable in five equal annual installments beginning on August 1, 2008.
(10) The stock option became exercisable in five equal annual installments beginning on June 11, 2009.
(11) The stock option became exercisable in five equal annual installments beginning on June 10, 2010.
(12) The stock option became exercisable in five equal annual installments beginning on September 8, 2011.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.